Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 6/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | PPIA | P62937 | 2/20 | 0.38 |
| ▸ | PYGL | P06737 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | PTGFR | P43088 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6514583 | 0.90 | MEN1 (0.52) | ATMMEN1KMT2AMAPTUSP2 | |
| SCHEMBL6502474 | 0.85 | ATM (0.53) | ATMMEN1KMT2AMAPTUSP2 | |
| SCHEMBL6507276 | 0.85 | KMT2A (0.49) | ATMMEN1KMT2AMAPTUSP2 | |
| SCHEMBL6508055 | 0.83 | MEN1 (0.55) | ATMMEN1KMT2AMAPTUSP2 | |
| SCHEMBL6509959 | 0.82 | ATM (0.50) | ATMMEN1KMT2AMAPTUSP2 | |
| SCHEMBL6505906 | 0.82 | MEN1 (0.60) | ATMMEN1KMT2AMAPTUSP2 | |
| SCHEMBL6509567 | 0.82 | ATM (0.50) | ATMMEN1KMT2AMAPTUSP2 | |
| SCHEMBL5310875 | 0.81 | ATM (0.53) | ATMMEN1KMT2AMAPTUSP2 | |
| SCHEMBL6503189 | 0.80 | RAB9A (0.50) | ATMMEN1KMT2AMAPTUSP2 | |
| SCHEMBL5311613 | 0.80 | MEN1 (0.48) | ATMMEN1KMT2AMAPTUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007066496-A1 | BENZOYLUREA COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-06-14 | — | — | WO | disclosed |
| US-20050159599-A1 | Cyclic compound, process for producing the same, and pest control agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-07-21 | — | — | US | disclosed |
| WO-2005040112-A1 | COMPOUNDS WITH PGD2 ANTAGONIST ACTIVITY | OXAGEN LIMITED (GB) | 2005-05-06 | — | — | WO | disclosed |
| EP-1481972-A1 | CYCLIC COMPOUND, PROCESS FOR PRODUCING THE SAME, AND PEST CONTROL AGENT | Sumitomo Chemical Takeda Agro Company, Limited (JP) | 2004-12-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050159599-A1 | Cyclic compound, process for producing the same, and pest control agent | CNPY2, CNPY3, HAX1 | ATM 2564/4885MEN1 2593/4885KMT2A 1362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.